Roche and Eli Lilly have started testing a blood test that could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans a
The FDA had reservations about the efficacy of Roche’s Polivy as a first-line regimen alongside chemotherapy for diffuse large B-cell lymphoma (DLBCL), but its advisors fe
Two and a half years after France’s competition authority handed Novartis and Roche a hefty fine for allegedly using abusive practices to boost sales of their eye disease
Roche is on course for a third indication for its fast-growing ophthalmic disease therapy Vabysmo, after a pair of phase 3 trials showed it was effective at improving eyes
Roche is preparing regulatory filings for its crovalimab antibody for rare disease paroxysmal nocturnal haemoglobinuria (PNH), after a phase 3 trial showed the drug was as
Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t